PILA PHARMA AB Financial Overview
PILA PHARMA AB's market cap is currently €8.43M. The company's EPS TTM is €-0.012339000000000001; its P/E ratio is ―; PILA PHARMA AB is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
